About Dana-Farber Cancer Institute
Since its founding in 1947, Dana-Farber Cancer Institute has been committed to reducing the burden of cancer for adults and children through scientific inquiry, clinical care, education, community engagement, and advocacy. Dana-Farber is dedicated to a unique and equal balance between cancer research and care, translating the results of discovery into new treatments for patients locally and around the world.
Dana-Farber's equal commitment to research and patient care is unique among cancer centers and results in an extraordinary level of collaboration between scientists and clinicians, speeding the translation of laboratory discoveries into lifesaving treatments for patients all over the world.
- Learn more about Dana-Farber Cancer Institute
In October 2017, the Institute embarked on the most ambitious fundraising campaign in its history to defy cancer. The Dana-Farber Campaign will accelerate success with revolutionary science, extraordinary care, and exceptional expertise. We are the only hospital in New England to announce a $2 billion campaign focused solely on cancer. Our visionary trailblazers, medical pioneers, and compassionate caregivers are changing the future of cancer. Progress is accelerating and successes are multiplying as we tackle the challenge that will yield, what is likely to be considered, one of the greatest victories in human history.
- Learn more about The Dana-Farber Campaign
The Institute employs over 4,000 people supporting more than 380,000 patient visits a year, is involved in more than 1,200 clinical trials annually, and is internationally renowned for its blending of research and clinical excellence. It has been the top ranked cancer center in New England by U.S. News and World Report for 20 consecutive years, and is the only cancer center in the country ranked in the top 6 for both adult and pediatric cancer programs.
Dana-Farber is a principal teaching affiliate of Harvard Medical School and a founding member of the Dana-Farber/Harvard Cancer Center and the Center for AIDS Research at Harvard University. Dana-Farber faculty access resources and scientific expertise in highly specialized fields through the Institute's associations with the Harvard Stem Cell Institute, Harvard's NIH Clinical and Translational Science Center, and the Broad Institute of MIT and Harvard, a center of genomic research where several Dana-Farber faculty members have joint appointments.
Providing advanced training in cancer treatment and research for an international faculty, the Institute conducts community-based programs in cancer prevention, detection, and control throughout New England, and maintains joint programs with other Boston institutions affiliated with Harvard Medical School, including Brigham and Women's Hospital and Boston Children's Hospital.
- Learn more about working in our Division of Philanthropy